Market Cap (In AUD)
1.1 Billion
Revenue (In AUD)
1.74 Billion
Net Income (In AUD)
-645.8 Million
Avg. Volume
2.33 Million
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.08-1.86
- PE
- -1.59
- EPS
- -0.96
- Beta Value
- 0.743
- ISIN
- AU0000033359
- CUSIP
- Q4548G107
- CIK
- -
- Shares
- 726133000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Paul D. Anderson B.Com., C.A.
- Employee Count
- -
- Website
- https://www.healius.com.au
- Ipo Date
- 1998-08-03
- Details
- Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
More Stocks
-
5618NYLE INC
5618
-
3311
-
PKBKParke Bancorp, Inc.
PKBK
-
004690Samchully Co.,Ltd
004690
-
GOLDIAMGoldiam International Limited
GOLDIAM
-
ABR
-
NRP
-
GDMRFCanxgold Mining Corp.
GDMRF